An experimental cancer vaccine developed at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy has shown early promise in a phase I clinical trial for a rare form of liver cancer that primarily affects children and young adults.

A US study of more than a million Medicaid enrollees, newly diagnosed with opioid use disorder (OUD), finds most – nearly seven in 10 – are not receiving access to potentially life-saving drugs within six months. 

New research, led by LJI scientists, offers a potential way to boost tissue-resident memory T cell numbers to better fight disease.

Crimean-Congo hemorrhagic fever is a highly lethal, tick-borne disease found across Africa, Asia, Eastern Europe, and the Middle East, yet it remains understudied and without approved treatments or vaccines. A new study in npj Vaccines reports a promising vaccine made from a non-infectious form of the virus. In mice, it provided rapid protection and long-lasting immunity, offering new hope for preventing this deadly infection.